Patent · US Active

Inhibitors of Flaviviridae viruses

US8524764B2 · kind B2 · utility

20Cited by

6References

20Claims

0Family size

Assignee

Gilead Sciences, Inc. · US

Inventors

Eda Canales · San Mateo, US
Lee S. Chong · Newark, US
Michael O' Neil Hanrahan Clarke · Redwood City, US
Edward Doerffler · Reno, US
Scott E. Lazerwith · Foster City, US
Willard Lew · San Mateo, US
Michael Mertzman · Belmont, US
Philip Anthony Morganelli · Oakland, US
William J. Watkins · Saratoga, US

Key dates

Filing date	Jan 14, 2011
Grant date	Sep 3, 2013
Priority date	—
Expiry date	Apr 23, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are compounds of Formula I:and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.